Using microarray cards, our laboratory quantified 45 selected exosomal miRNAs in plasma of 435 HER2-positive BC and TNBC patients undergoing treatment with paclitaxel and non-pegylated liposomal doxorubicin with or without addition of carboplatin. This evidence concerns the gene ERBB2 and breast cancer.